Coagulant activity during one year after bioprosthetic aortic valve replacement
نویسندگان
چکیده
منابع مشابه
Ventriculo-atrial defect after bioprosthetic aortic valve replacement
We present a case of a 71-year-old Caucasian male with a ventriculo-atrial defect due to infective endocarditis, originating from his aortic root near a bioprosthetic aortic valve, implanted 4 years earlier. Ventriculo-atrial defects are rare and can occur after endocarditis with abscess formation, usually in native tissue. We report a ventriculo-atrial defect due to a paravalvular aortic prost...
متن کاملErratum: Ventriculo-atrial defect after bioprosthetic aortic valve replacement
Author details Department of Anesthesia and Pain Medicine, University of Groningen, University Medical Center, Groningen, The Netherlands. Department of Cardiothoracic Surgery, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. Department of Anesthesia Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medi...
متن کاملRare complication of bioprosthetic aortic valve replacement.
CE-Perimount aortic bioprosthesis in a 59-year-old-man, implanted 8 years ago, showed non-infective severe structural deterioration. Preoperative echocardiogram demonstrated a prolapsing cusp (Fig. 1(A—C)); however, intra-operative echocardiogram and findings revealed a ‘missing’ leaflet (Figs. 1(D), 2(A and B) and Video 1). www.elsevier.com/locate/ejcts European Journal of Cardio-thoracic Surg...
متن کاملAntithrombotic therapy following bioprosthetic aortic valve replacement.
The life expectancy of the general population is increasing. This has meant that more elderly patients are requiring aortic valve replacement (AVR). The choice of valve replacement and its durability are important. Bioprosthetic (tissue) heart valves were introduced into clinical use in the 1960s and were developed primarily to reduce the complications associated with thromboembolism (TE) and t...
متن کاملTranscatheter aortic valve replacement for bioprosthetic aortic valve failure: the valve-in-valve procedure.
2542 B ioprosthetic valves are increasingly used in patients with aortic stenosis. Compared with mechanical valves, bio-prosthetic valves are associated with a lower risk of thrombo-embolic events and do not require long-term anticoagulation. 1,2 However, bioprosthetic valves have limited durability; the best current valves can be expected to degenerate within 10 to 20 years, resulting in steno...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Interactive CardioVascular and Thoracic Surgery
سال: 2009
ISSN: 1569-9293,1569-9285
DOI: 10.1510/icvts.2008.196675